Validated Scale Helps Measure Treatment-Induced Neuropathy in Chinese Patients
Skip to content
The CRC Digest
Validated Scale Helps Measure Treatment-Induced Neuropathy in Chinese Patients
A prospective study of 254 colorectal cancer patients receiving oxaliplatin validated the Treatment-induced Neuropathy Assessment Scale (TNAS) and established cutpoints for numbness, sensory symptoms, and interference with daily activities. (Quality of Life Research)
This content